---
$id: https://graph.org.ai/products/commodity/51111650
$type: Product
source: UNSPSC
code: "51111650"
title: "Pemetrexed"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pemetrexed

**UNSPSC Code**: 51111650
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thymidylate synthase inhibitor and folate antagonist with the molecular formula C20H21N5O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 04Q9AIZ7NO, chemically known as n-(4-(2-(2-amino-3,4-dihydro-4-oxo-7h-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid but generally known as pemetrexed, which bears US NIH Compound Identifier 60843. European Medicines Agency schedules Pemetrexed in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09655MIG. The term PEMETREXED is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules pemetrexed in its Anatomical Therapeutic Chemical (ATC) Classification. PEMETREXED is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pemetrexed under HS 29335995 and SITC 51576. As of Q4 2014, PEMETREXED remains the US FDA Preferred Term for this commodity. Pemetrexed bears US NLM identifiers UMLS ID C0210657 and NCI Concept Code C61614. SMILES: O=C1NC([NH]C2[NH]CC(CCC3CCC(CC3)C(=O)NC(CCC(=O)O)C(=O)O)C12)N.

